Therapeutic benefits of Sideroxylon obtusifolium (Humb. ex Roem. & Schult.) T.D. Penn., Sapotaceae, in experimental models of pain and inflammation;Benefícios terapêuticos da Sideroxylon obtusifolium (Humb. ex Roem. & Schult.) T.D. Penn., Sapotaceae, em modelos experimentais de dor e inflamação

Revista Brasileira de Farmacognosia

Volumn 20, Issue 6, 2010, Pages 933-938

  Araujo Neto, Vitor ^a   Bomfim, Rangel R ^a   Oliveira, Valter O B ^a   Passos, Ailane M P R ^a   Oliveira, Juliana P R ^a   Lima, Clésio A ^a   Mendes, Sandra S ^a   Estevam, Charles S ^a   Thomazzi, Sara M ^a  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

Author keywords

Anti inflammatory; Antinociceptive; Sapotaceae; Sideroxylon obtusifolium

Indexed keywords

ACETIC ACID; ACETYLSALICYLIC ACID; ALCOHOL; CARRAGEENAN; DEXAMETHASONE; FLAVANONE; FLAVONOL; FLAVONONOL; FORMALDEHYDE; MORPHINE; PHENOL; PHYTOSTEROL; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; SAPONIN; SIDEROXYLON OBTUSIFOLIUM EXTRACT; TANNIN; TRITERPENE; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BARK; CONTROLLED STUDY; DOSE RESPONSE; DRUG SCREENING; FEMALE; HOT PLATE TEST; INFLAMMATION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PAIN; PAW EDEMA; PERITONEAL CAVITY; RAT; SAPOTACEAE; SIDEROXYLON OBTUSIFOLIUM; SOLVENT EXTRACTION;

EID: 79551663573     PISSN: 0102695X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0102-695X2010005000043     Document Type: Article

References (28)

1. Albuquerque UP, Monteiro JM, Ramos MA, Amorim ELC 2007. Medicinal and magic plants from a public market in northeastern Brazil. J Ethnopharmacol 110: 76-91.
2. Albuquerque UP, Oliveira RF 2007. Is the use-impact on native caatinga species in Brazil reduced by the high species richness of medicinal plants? J Ethnopharmacol 113: 156-170.
3. Bastos LF, Merlo LA, Rocha LT, Coelho MM 2007. Characterization of the antinociceptive and anti-inflammatory activities of doxycycline and minocycline in different experimental models. Eur J Pharmacol 576: 171-179.
4. Beltrão AES, Tomaz ACA, Beltrão FAS, Marinho P 2008. In vitro biomass production of Sideroxylon obtusifolium (Roem & Schult). Rev bras farmacogn 18: 696-698.
5. Carvalho JCT 2004. Fitoterápicos antiinflamatórios: aspectos químicos, farmacológicos e aplicações terapêuticas. Ribeirão Preto: Tecmedd Editora.
6. Dawson J, Sedgwick AD, Edwards JC, Lees P 1991. A comparative study of the cellular, exudative and histological responses to carrageenan, dextran and zymosan in the mouse. Int J Tissue React 13: 171-185.
7. Desmarchelier C, Romão RL, Coussio J, Ciccia G 1999. Antioxidant and free radical scavenging activities in extracts from medicinal trees used in the 'Caatinga' region in northeastern Brazil. J Ethnopharmacol 67: 69-77.
8. Duarte ID, Nakamura M, Ferreira SH 1988. Participation of the sympathetic system in acetic acid-induced writhing in mice. Braz J Med Biol Res 21: 341-343.
9. Dubuisson D, Dennis SG 1977. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4: 161-174.
10. Eddy NB, Leimbach D 1953. Synthetic analgesics. II. Dithienylbutenyland dithienylbutylamines. J Pharmacol Exp Ther 107: 385-393.
11. Filipoy A 1994. Medicinal plant of the Pilage of Central Chaco. J Ethnopharmacol 44: 181-193.
12. Harborne JB 1984. Phytochemical methods: A guide to modern techniques of plant analysis. London: Chapman and Hall.
13. Hunskaar S, Hole K 1987. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30: 103-114.
14. Koster R, Anderson N, Debber EJ 1959. Acetic acid for analgesic screening. Fed Proc 18: 418-420.
15. Loram LC, Fuller A, Fick LG, Cartmell T, Poole S, Mitchell D 2007. Cytokine profiles during carrageenan-induced inflammatory hyperalgesia in rat muscle and hind paw. J Pain 8: 127-136.
16. Meotti FC, Luiz AP, Pizzolatti MG, Kassuya CAL, Calixto JB, Santos ARS 2006. Analysis of the antinociceptive effect of the flavonoid myricitrin: evidence for a role of the l-arginine-nitric oxide and protein kinase C pathways. J Pharmacol Exp Ther 316: 789-796.
17. Nantel F, Denis D, Gordon R, Northey A, Cirino M, Metters KM, Chan CC 1999. Distribution and regulation of cyclooxygenase-2 in carrageenan induced inflammation. Braz J Pharmacol 128: 853-859.
18. Nijveldt RJ, Van-Nood E, Van-Hoorn DEC, Boelens PG, Van-Norren K, Van-Leeuwer PAM 2001. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 74: 418-425.
19. Odontuya G, Hoult JRS, Houghton PJ 2005. Structure-activity relationship for anti-inflammatory effect of luteolin and its derived glycosides. Phytother Res 19: 782-786.
20. Reichert JA, Daughters RS, Rivard R, Simone DA 2001. Peripheral and preemptive opioid antinociception in a mouse visceral pain model. Pain 89: 221-227.
21. Salvemini D, Wang ZQ, Wyatt PS, Bourdon DM, Marino MH, Manning PT, Currie MG 1996. Nitric oxide: a key mediator in the early and late phase of carrageenaninduced rat paw inflammation. Brit J Pharmacol 118: 829-838.
22. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, Lee L, Isakson P 1994. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. P Natl Acad Sci USA 91: 12013-12017.
23. Shibata M, Ohkubo T, Takahashi H, Inoki R 1989. Modified formalin test: characteristic biphasic pain response. Pain 38: 347-352.
24. Soobrattee MA, Neergheen VS, Luximon-Ramma A, Aruoma OI, Bahorun T 2005. Phenolics as potential antioxidant therapeutic agents: mechanism and actions. Mutat Res 579: 200-213.
25. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K 1992. The formalin test: an evaluation of the method. Pain 51: 5-17.
26. Willain-Filho A, Cechinel-Filho V, Olinger L, Souza MM 2008. Quercetin: further investigation of its antinociceptive properties and mechanisms of action. Arch Pharm Res 31: 713-721.
27. Winter CA, Risley EA, Nuss GW 1962. Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. P Soc Exp Biol Med 111: 544-547.
28. Woolfe G, Macdonald AD 1944. The evaluation of the analgesic action of penthidine hydrochloride (Demerol). J Pharmacol Exp Ther 80: 300.